Catalyst Wire Dossier Catalyst Wire Dossier

Equidacent

bevacizumab · Centus Biotherapeutics Europe Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Equidacent, covering 2021-11-25 to 2021-11-25. Get the full timeline:

Most recent: EMA Withdrawn: Equidacent (bevacizumab) — Centus Biotherapeutics Europe Limited

See pricing